GO:0051087 protein-folding chaperone binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051087 (protein-folding chaperone binding) is a molecular function describing the binding of a protein to a chaperone, a class of proteins that bind nascent or unfolded polypeptides to ensure correct folding or transport.
• Chaperone binding is the physical basis of co-chaperone and co-chaperonin activity, enabling the Hsp70-Hsp90 cascade and the CCT/TRiC folding machine to coordinate substrate handover.
• The interaction is often transient and depends on weak, multivalent contacts, allowing a substrate to fold while still chaperone-bound.
• Chaperone binding is central to co-translational folding in bacteria, where trigger factor and DnaK coordinate with the ribosome exit tunnel.
• Dysregulated chaperone binding is implicated in cancer, neurodegeneration and other proteostasis disorders, making it a target for mechanistic and therapeutic studies.
• CRISPR knockout, point-mutation, knock-in and overexpression models are the standard tools to test whether a candidate chaperone-binding protein is causally involved in folding and disease.
Description
GO:0051087, protein-folding chaperone binding, is a molecular function that captures the direct physical interaction between a protein and a chaperone. The chaperone is defined as a protein that binds nascent or unfolded polypeptides and helps them fold or be transported correctly. This function is not a catalytic activity in the classical sense; it is a binding event that positions a substrate for folding, prevents aggregation, or hands the substrate to a downstream chaperone. Because almost every cellular pathway depends on correctly folded proteins, chaperone binding is a recurring node in proteostasis, stress responses and disease. Mechanistically, chaperone binding is best understood through the Hsp70 and Hsp90 systems. Hsp70 binds exposed hydrophobic segments of unfolded polypeptides in an ATP-dependent cycle, and Hsp90 subsequently binds a subset of these clients to mature them. In the eukaryotic cytosol, the CCT/TRiC complex uses chaperone binding to enclose and fold actin, tubulin and other essential proteins. In bacteria, trigger factor and DnaK bind nascent chains as they emerge from the ribosome, coupling chaperone binding to translation. These examples show that GO:0051087 is a shared functional module across all domains of life. For researchers, GO:0051087 is a practical annotation target. It tells you that a gene product is expected to bind a chaperone, which immediately suggests experiments: co-immunoprecipitation, crosslinking, fluorescence polarization, and CRISPR-based perturbation of the binding interface. It also links a candidate gene to disease modules such as cancer and neurodegeneration, where chaperone binding is often rewired. This article summarizes the definition, mechanism, key genes, disease links and research methods for GO:0051087, with all factual claims tied to the verified literature.
protein-folding chaperone binding At A Glance
| GO ID | GO:0051087 |
|---|---|
| GO term | protein-folding chaperone binding |
| Ontology | molecular_function |
| Definition | Binding to a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport. |
| Synonyms | chaperone binding; chaperone protein binding; co-chaperone activity; co-chaperonin activity |
| Major function | Physical interaction with chaperones such as Hsp70, Hsp90 and CCT/TRiC to support protein folding, maturation and transport. |
| Representative chaperones | HSPA1A/Hsp70, HSP90AA1/Hsp90, CCT subunits, DnaK, trigger factor. |
| Related processes | Protein folding, proteostasis, stress response, co-translational folding. |
| Experimental readouts | Co-immunoprecipitation, crosslinking, fluorescence polarization, CRISPR perturbation. |
What Is GO:0051087?
In plain terms, GO:0051087 means a protein can grab onto a chaperone. The QuickGO definition states that this function is the binding to a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport. It is a molecular function, not a biological process or a cellular component. Synonyms include chaperone binding, chaperone protein binding, co-chaperone activity and co-chaperonin activity. The term is used when the experimental evidence shows a direct physical interaction between the annotated protein and a chaperone, regardless of whether the annotated protein is a substrate, a co-chaperone, or a regulatory partner.
Why Is protein-folding chaperone binding Important in Cell Biology?
GO:0051087 matters because chaperone binding is the decision point that determines whether a polypeptide folds, is handed to another chaperone, or is degraded. The Hsp70-Hsp90 cascade is a textbook example: Hsp70 binds first, then Hsp90 binds a subset of clients, and the handover is mediated by co-chaperones that themselves bind chaperones. In the cytosol, CCT/TRiC uses chaperone binding to fold actin and tubulin, which are essential for cell shape and division. In bacteria, co-translational chaperone binding by trigger factor and DnaK protects nascent chains as they emerge from the ribosome. When chaperone binding is impaired, proteins misfold and aggregate, which is a common theme in cancer and neurodegeneration. Therefore, annotating a gene with GO:0051087 is a strong clue that it participates in proteostasis and is worth testing in disease models.
• Chaperone binding is the first step in the Hsp70-Hsp90 folding cascade, which matures kinases, steroid receptors and many oncoproteins.
• CCT/TRiC chaperone binding is required for folding actin and tubulin, making it essential for cytoskeleton function.
• Co-translational chaperone binding in bacteria couples folding to translation and prevents aggregation of nascent chains.
• Weak, multivalent chaperone-substrate interactions allow folding to continue while the substrate is still bound.
• Chaperone binding is often rewired in cancer, where Hsp90 and Hsp70 support oncogenic clients.
• Neurodegenerative diseases involve failed chaperone binding and accumulation of misfolded proteins.
• Metabolite-binding proteins can moonlight as chaperones, expanding the functional repertoire of chaperone binding.
• CRISPR screens can identify genes whose chaperone-binding function is required for stress survival.
• Chaperone binding is a druggable interface, and inhibitors of Hsp90 and Hsp70 are in clinical development.
• GO:0051087 annotations help prioritize candidate genes for mechanistic studies of proteostasis.
Molecular Mechanism of protein-folding chaperone binding
Substrate recognition by Hsp70
In simple terms: Hsp70 grabs unfolded proteins by their sticky, hydrophobic parts.
Hsp70 chaperones bind short hydrophobic segments exposed by unfolded polypeptides. The binding is ATP-dependent: ATP-bound Hsp70 has low affinity, and ATP hydrolysis locks the substrate in place. This cycle is the foundation of chaperone binding in the cytosol, mitochondria and endoplasmic reticulum. The Hsp70-Hsp90 cascade then transfers a subset of clients to Hsp90 for maturation.
Handover to Hsp90
In simple terms: Hsp90 takes over some proteins after Hsp70 has bound them.
Hsp90 binds a more folded set of clients, including kinases and steroid hormone receptors. The handover from Hsp70 to Hsp90 is coordinated by co-chaperones such as Hop and p23, which themselves bind chaperones and are annotated with GO:0051087. This cascade illustrates how chaperone binding is not a single event but a relay.
Chaperonin binding in the CCT/TRiC complex
In simple terms: A barrel-shaped chaperonin closes around a protein and gives it a private folding chamber.
CCT/TRiC is a eukaryotic chaperonin that binds actin, tubulin and other substrates inside a closed chamber. Chaperone binding here is mediated by the apical domains of the CCT subunits, and the substrate folds while bound. Recent structural work has visualized the folding trajectory of a G protein beta-propeller inside the chaperonin, showing that chaperone binding is compatible with progressive folding.
Co-translational chaperone binding
In simple terms: Chaperones can grab a protein while it is still being made by the ribosome.
In bacteria, trigger factor binds the ribosome and nascent chains, and DnaK can also engage emerging polypeptides. This co-translational chaperone binding prevents premature folding and aggregation. The same principle applies in eukaryotes, where ribosome-associated chaperones bind nascent chains as they exit the tunnel.
Weak interactions and folding while bound
In simple terms: The grip is loose enough that the protein can still fold.
Chaperone binding is often mediated by weak, multivalent interactions. Single-molecule and biochemical studies show that a substrate can fold while still bound to a chaperone, because the interaction is dynamic and does not lock the polypeptide into a single conformation. This explains why chaperone binding can be both protective and permissive.
Moonlighting chaperone binding
In simple terms: Some proteins have a second job as chaperones.
Metabolite-binding proteins can moonlight as chaperones. For example, a bile-responsive metabolite-binding protein can act as a chaperone, demonstrating that chaperone binding is not limited to classical heat-shock proteins. This expands the set of proteins that may be annotated with GO:0051087.
Key Genes Involved in GO:0051087 protein-folding chaperone binding
The following genes encode chaperones or chaperone-binding proteins that are directly relevant to GO:0051087, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HSPA1A | Hsp70 chaperone that binds unfolded polypeptides | Core Hsp70 substrate binding and ATP cycle |
| HSP90AA1 | Hsp90 chaperone that binds client kinases and receptors | Hsp90 client maturation and cancer |
| HSPA8 | Hsc70 constitutive Hsp70 family member | Chaperone binding in housekeeping proteostasis |
| DNAK | Bacterial Hsp70 homolog | Co-translational chaperone binding in bacteria |
| TIG | Trigger factor, bacterial ribosome-associated chaperone | Co-translational chaperone binding |
| CCT1 | Subunit of CCT/TRiC chaperonin | Actin and tubulin folding |
| CCT2 | Subunit of CCT/TRiC chaperonin | Chaperonin substrate binding |
| CCT3 | Subunit of CCT/TRiC chaperonin | Chaperonin substrate binding |
| CCT4 | Subunit of CCT/TRiC chaperonin | Chaperonin substrate binding |
| CCT5 | Subunit of CCT/TRiC chaperonin | Chaperonin substrate binding |
| CCT6A | Subunit of CCT/TRiC chaperonin | Chaperonin substrate binding |
| CCT7 | Subunit of CCT/TRiC chaperonin | Chaperonin substrate binding |
| CCT8 | Subunit of CCT/TRiC chaperonin | Chaperonin substrate binding |
| STIP1 | Co-chaperone that binds Hsp70 and Hsp90 | Hsp70-Hsp90 handover |
| PTGES3 | p23 co-chaperone that binds Hsp90 | Hsp90 client maturation |
| AHSA1 | Aha1 co-chaperone that binds Hsp90 | Hsp90 ATPase regulation |
| GNB5 | G protein beta5, a CCT/TRiC substrate | Chaperonin-mediated folding trajectory |
How Is protein-folding chaperone binding Regulated?
Chaperone binding is regulated at multiple levels. Hsp70 binding is controlled by its ATPase cycle, which is accelerated by J-domain co-chaperones and nucleotide exchange factors. Hsp90 binding is regulated by co-chaperones such as Aha1 and p23, which modulate its ATPase and client maturation. The Hsp70-Hsp90 cascade is further coordinated by Hop/STIP1, which binds both chaperones and facilitates handover. In bacteria, co-translational chaperone binding is regulated by the ribosome and by the availability of trigger factor and DnaK. In the CCT/TRiC system, substrate binding is regulated by the chaperonin's ATP cycle and by the geometry of its apical domains. Finally, weak interactions allow dynamic exchange, so the lifetime of a chaperone-substrate complex is itself a regulatory parameter.
protein-folding chaperone binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HSP90AA1 | Cancer, client kinase maturation | Knockout or point-mutation of ATPase domain in cancer cell lines |
| HSPA1A | Neurodegeneration, protein aggregation | Knockout and overexpression in neuronal models |
| CCT5 | Cytoskeletal folding defects | Knockout in cell lines to test actin/tubulin folding |
| STIP1 | Hsp70-Hsp90 handover in cancer | Knock-in of tagged STIP1 for interaction studies |
| GNB5 | G protein folding and signaling | CCT/TRiC substrate folding assays |
Cancer
Hsp90 and Hsp70 chaperone binding supports the maturation of oncogenic kinases and steroid receptors. Inhibitors of Hsp90 ATPase activity disrupt chaperone binding and have been tested in cancer clinical trials. The Hsp70-Hsp90 cascade is therefore a therapeutic axis in oncology.
Neurodegeneration
Failed chaperone binding contributes to the accumulation of misfolded proteins in neurodegenerative diseases. Hsp70 and Hsp90 chaperone binding is part of the cellular defense against protein aggregation, and its decline is linked to disease progression.
Proteostasis and metabolic stress
Chaperone binding is required for folding actin and tubulin, and its disruption affects cytoskeletal integrity. Moonlighting chaperones such as metabolite-binding proteins can also respond to bile and other metabolites, linking chaperone binding to metabolic stress.
From protein-folding chaperone binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is the chaperone-binding interface required for client maturation? | Point mutation of the chaperone-binding domain |
| Does loss of the gene impair folding of a specific substrate? | CRISPR knockout followed by proteomics |
| Can a tagged chaperone be used to purify complexes? | Knock-in of an epitope tag |
| Does overexpression of the chaperone protect against stress? | Overexpression cell model |
| Which genes are required for chaperone binding under stress? | CRISPR library screening |
| Does a disease mutation alter chaperone binding? | Knock-in of the patient mutation |
How to Study the protein-folding chaperone binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Physical interaction between chaperone and substrate | Validation of GO:0051087 annotation |
| Crosslinking mass spectrometry | Binding interface and dynamic contacts | Mapping chaperone-substrate interfaces |
| Fluorescence polarization | Binding affinity and kinetics | Weak interaction measurements |
| Single-molecule FRET | Conformational changes during binding | Folding while chaperone-bound |
| CRISPR knockout screen | Genes required for chaperone binding | Proteostasis pathway discovery |
| Proteomics | Client folding and stability | Substrate identification |
| Ribo-seq | Co-translational chaperone engagement | Bacterial co-translational folding |
| Structural biology (cryo-EM) | Chaperonin-substrate architecture | CCT/TRiC folding trajectory |
Co-immunoprecipitation and affinity purification
Co-immunoprecipitation with an antibody against the chaperone or the substrate is the classic way to detect GO:0051087. Tagged knock-in lines allow purification of endogenous complexes under near-physiological conditions.
Crosslinking and mass spectrometry
Crosslinking mass spectrometry can map the chaperone-binding interface and identify dynamic interactions that are too weak to survive immunoprecipitation.
Fluorescence polarization and single-molecule assays
Fluorescence polarization and single-molecule FRET can measure the affinity and lifetime of chaperone-substrate complexes, revealing weak interactions that allow folding while bound.
CRISPR screens and proteomics
CRISPR knockout screens combined with proteomics can identify genes whose chaperone-binding function is required for folding or stress survival.
How CRISPR Can Be Used to Study GO:0051087 protein-folding chaperone binding
Knockout
CRISPR knockout of a chaperone or chaperone-binding protein removes the function entirely, allowing researchers to test whether GO:0051087 is required for substrate folding, stress survival or disease phenotypes.
Point Mutation
Point mutations in the chaperone-binding interface can separate binding from other functions. For example, mutating the Hsp90 ATPase domain disrupts chaperone binding and client maturation. Similar point mutations in Hsp70 can test the ATP-dependent binding cycle.
Knock-in
Knock-in of an epitope tag or a disease-associated mutation allows endogenous-level study of chaperone binding. Tagged knock-in lines are ideal for co-immunoprecipitation and interaction proteomics.
Overexpression
Overexpression of a chaperone or co-chaperone can amplify chaperone binding and protect cells from stress. This is useful for testing whether increased chaperone binding is sufficient to rescue folding defects.
How EDITGENE Supports protein-folding chaperone binding Research
Researchers studying protein-folding chaperone binding-related genes often need to determine whether a candidate gene is causally involved in folding, stress responses or disease. EDITGENE provides the CRISPR models and screening services needed to move from annotation to mechanism.
Contact EDITGENE today to design your custom CRISPR model for protein-folding chaperone binding research.
Frequently Asked Questions About protein-folding chaperone binding
What is GO:0051087?
GO:0051087 is the molecular function protein-folding chaperone binding, defined as binding to a chaperone protein that binds nascent or unfolded polypeptides to ensure correct folding or transport.
What genes are involved in protein-folding chaperone binding?
Key genes include HSPA1A, HSP90AA1, HSPA8, DNAK, TIG, the CCT subunits, STIP1, PTGES3, AHSA1 and GNB5.
What is the difference between chaperone binding and protein folding?
Chaperone binding is the physical interaction with a chaperone, while protein folding is the process by which a polypeptide reaches its functional conformation; chaperone binding supports folding but is not folding itself.
How is chaperone binding regulated?
It is regulated by ATP cycles, co-chaperones such as Hop and p23, and the availability of substrates; weak interactions allow dynamic exchange.
Which diseases are linked to chaperone binding?
Cancer, neurodegeneration and cytoskeletal folding defects are linked to altered chaperone binding.
What methods study chaperone binding?
Co-immunoprecipitation, crosslinking mass spectrometry, fluorescence polarization, single-molecule FRET, CRISPR screens and proteomics are commonly used.
Can CRISPR knockout be used to study chaperone binding?
Yes, knockout of a chaperone or chaperone-binding protein removes the function and allows loss-of-function tests of folding and disease phenotypes.
What is a co-chaperone?
A co-chaperone is a protein that binds a chaperone and regulates its activity; co-chaperone activity is a synonym for GO:0051087.
Is chaperone binding ATP-dependent?
For Hsp70 and Hsp90, chaperone binding is coupled to ATP hydrolysis, while some interactions are ATP-independent.
How do I annotate a gene with GO:0051087?
Annotation requires experimental evidence of direct binding to a chaperone, typically from co-immunoprecipitation, crosslinking or structural studies.
Conclusion
GO:0051087, protein-folding chaperone binding, is a compact molecular function with broad biological reach. It underlies the Hsp70-Hsp90 cascade, the CCT/TRiC chaperonin system and co-translational folding in bacteria. Its dynamic, often weak interactions allow substrates to fold while bound, which is essential for proteostasis. Because chaperone binding is rewired in cancer and neurodegeneration, it is a high-value target for CRISPR-based mechanistic studies. Researchers can now use knockout, point-mutation, knock-in and overexpression models, together with CRISPR screening and bioinformatics, to test causality for any candidate gene annotated with GO:0051087.
References
- 1. Schopf FH et al.. 2017. The HSP90 chaperone machinery.. Nat Rev Mol Cell Biol 18(6):345-360 PMID: 28429788
- 2. Mayer MP et al.. 2005. Hsp70 chaperones: cellular functions and molecular mechanism.. Cell Mol Life Sci 62(6):670-84 PMID: 15770419
- 3. Morán Luengo T et al.. 2019. The Hsp70-Hsp90 Chaperone Cascade in Protein Folding.. Trends Cell Biol 29(2):164-177 PMID: 30502916
- 4. Roeselová A et al.. 2024. Mechanism of chaperone coordination during cotranslational protein folding in bacteria.. Mol Cell 84(13):2455-2471.e8 PMID: 38908370
- 5. Shen PS et al.. 2025. Protein folding by the CCT/TRiC chaperone complex.. Curr Opin Struct Biol 91:102999 PMID: 39914052
- 6. Wang S et al.. 2023. Visualizing the chaperone-mediated folding trajectory of the G protein β5 β-propeller.. Mol Cell 83(21):3852-3868.e6 PMID: 37852256
- 7. Wu K et al.. 2019. Protein folding while chaperone bound is dependent on weak interactions.. Nat Commun 10(1):4833 PMID: 31645566
- 8. Lee C et al.. 2020. A metabolite binding protein moonlights as a bile-responsive chaperone.. EMBO J 39(20):e104231 PMID: 32882062
